Mynd Lifesciencs Stock Performance
| MYNDF Stock | USD 0.01 0.00 0.00% |
The company secures a Beta (Market Risk) of -1.47, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning MYND Lifesciencs are expected to decrease by larger amounts. On the other hand, during market turmoil, MYND Lifesciencs is expected to outperform it. At this point, MYND Lifesciencs has a negative expected return of -0.15%. Please make sure to verify MYND Lifesciencs' information ratio and kurtosis , to decide if MYND Lifesciencs performance from the past will be repeated at some future point.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days MYND Lifesciencs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
MYND |
MYND Lifesciencs Relative Risk vs. Return Landscape
If you would invest 1.38 in MYND Lifesciencs on November 13, 2025 and sell it today you would lose (0.57) from holding MYND Lifesciencs or give up 41.3% of portfolio value over 90 days. MYND Lifesciencs is currently producing negative expected returns and takes up 10.2345% volatility of returns over 90 trading days. Put another way, 91% of traded pink sheets are less volatile than MYND, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
MYND Lifesciencs Target Price Odds to finish over Current Price
The tendency of MYND Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.01 | 90 days | 0.01 | about 75.14 |
Based on a normal probability distribution, the odds of MYND Lifesciencs to move above the current price in 90 days from now is about 75.14 (This MYND Lifesciencs probability density function shows the probability of MYND Pink Sheet to fall within a particular range of prices over 90 days) .
MYND Lifesciencs Price Density |
| Price |
Predictive Modules for MYND Lifesciencs
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MYND Lifesciencs. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MYND Lifesciencs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
MYND Lifesciencs Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. MYND Lifesciencs is not an exception. The market had few large corrections towards the MYND Lifesciencs' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MYND Lifesciencs, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MYND Lifesciencs within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.03 | |
β | Beta against Dow Jones | -1.47 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | -0.02 |
MYND Lifesciencs Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MYND Lifesciencs for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MYND Lifesciencs can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| MYND Lifesciencs generated a negative expected return over the last 90 days | |
| MYND Lifesciencs has high historical volatility and very poor performance | |
| MYND Lifesciencs has some characteristics of a very speculative penny stock | |
| MYND Lifesciencs has a very high chance of going through financial distress in the upcoming years | |
| MYND Lifesciencs has accumulated 2 M in total debt with debt to equity ratio (D/E) of 0.9, which is about average as compared to similar companies. MYND Lifesciencs has a current ratio of 0.41, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist MYND Lifesciencs until it has trouble settling it off, either with new capital or with free cash flow. So, MYND Lifesciencs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MYND Lifesciencs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MYND to invest in growth at high rates of return. When we think about MYND Lifesciencs' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (4.37 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| MYND Lifesciencs has accumulated about 12.52 K in cash with (2.98 M) of positive cash flow from operations. | |
| Roughly 31.0% of MYND Lifesciencs outstanding shares are owned by corporate insiders |
MYND Lifesciencs Fundamentals Growth
MYND Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of MYND Lifesciencs, and MYND Lifesciencs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MYND Pink Sheet performance.
| Return On Asset | -2.01 | |||
| Operating Margin | 88.18 % | |||
| Current Valuation | 3.87 M | |||
| Shares Outstanding | 46.82 M | |||
| EBITDA | (4.31 M) | |||
| Cash And Equivalents | 12.52 K | |||
| Total Debt | 2 M | |||
| Debt To Equity | 0.90 % | |||
| Book Value Per Share | (0.06) X | |||
| Cash Flow From Operations | (2.98 M) | |||
| Earnings Per Share | (0.08) X | |||
| Total Asset | 2.67 M | |||
About MYND Lifesciencs Performance
By analyzing MYND Lifesciencs' fundamental ratios, stakeholders can gain valuable insights into MYND Lifesciencs' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MYND Lifesciencs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MYND Lifesciencs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. Mynd Life is traded on OTC Exchange in the United States.Things to note about MYND Lifesciencs performance evaluation
Checking the ongoing alerts about MYND Lifesciencs for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for MYND Lifesciencs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MYND Lifesciencs generated a negative expected return over the last 90 days | |
| MYND Lifesciencs has high historical volatility and very poor performance | |
| MYND Lifesciencs has some characteristics of a very speculative penny stock | |
| MYND Lifesciencs has a very high chance of going through financial distress in the upcoming years | |
| MYND Lifesciencs has accumulated 2 M in total debt with debt to equity ratio (D/E) of 0.9, which is about average as compared to similar companies. MYND Lifesciencs has a current ratio of 0.41, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist MYND Lifesciencs until it has trouble settling it off, either with new capital or with free cash flow. So, MYND Lifesciencs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MYND Lifesciencs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MYND to invest in growth at high rates of return. When we think about MYND Lifesciencs' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (4.37 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| MYND Lifesciencs has accumulated about 12.52 K in cash with (2.98 M) of positive cash flow from operations. | |
| Roughly 31.0% of MYND Lifesciencs outstanding shares are owned by corporate insiders |
- Analyzing MYND Lifesciencs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MYND Lifesciencs' stock is overvalued or undervalued compared to its peers.
- Examining MYND Lifesciencs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MYND Lifesciencs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of MYND Lifesciencs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MYND Lifesciencs' pink sheet. These opinions can provide insight into MYND Lifesciencs' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MYND Pink Sheet analysis
When running MYND Lifesciencs' price analysis, check to measure MYND Lifesciencs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MYND Lifesciencs is operating at the current time. Most of MYND Lifesciencs' value examination focuses on studying past and present price action to predict the probability of MYND Lifesciencs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MYND Lifesciencs' price. Additionally, you may evaluate how the addition of MYND Lifesciencs to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |